Nobel Prize in Medicine Awarded for Breakthrough in microRNA Gene Regulation
American biologists Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Medicine for their pioneering research on microRNAs, challenging traditional views on gene regulation. Their discovery may unlock new approaches to treating diseases such as cancer and cardiovascular conditions.
Published on April 5, 2025
The Nobel Assembly announced on October 7, 2024, that the Nobel Prize in Physiology or Medicine will be awarded to American biologists Victor Ambros and Gary Ruvkun. Their groundbreaking research on microRNAs has redefined our understanding of gene regulation by revealing that these small molecules play a critical role in controlling mRNA translation, rather than gene activity being solely controlled during transcription.
Ambros and Ruvkun’s discoveries not only illuminate the subtle mechanisms by which cells regulate functions such as nutrient absorption, neuron response, insulin secretion, and muscle contraction, but also open up promising avenues for future therapies. Their work is already drawing attention from major news outlets and holds potential implications for addressing complex diseases including cancer and cardiovascular conditions, even as clinical applications remain under investigation.